微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文
格隆汇3月14日丨Myomo(MYO.US)盘前继续上涨8.44%,报0.835美元,该股月内累计涨幅近20%,且昨日涨4%创阶段新高。公司2022年Q4财报实现营收404.2万美元,前值为403.2万美元,预期值为406万美元;每... 网页链接
$Myomo(MYO)$ 144 Report of proposed sale of securities Accession Number: 0000950170-24-052490 Act: 33 Size: 7 KB 网页链接
$Myomo(MYO)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-115944 Act: 34 Size: 12 MB 网页链接
$Myomo(MYO)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-115929 Act: 34 Size: 969 KB 网页链接
$Myomo(MYO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-115935 Act: 34 Size: 501 KB 网页链接
$Myomo(MYO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001622627-24-000024 Act: 34 Size: 94 KB 网页链接
$Myomo(MYO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-041921 Size: 4 KB 网页链接
$Myomo(MYO)$ 144 Report of proposed sale of securities Accession Number: 0000950170-24-040525 Act: 33 Size: 7 KB 网页链接
$Myomo(MYO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950170-24-038142 Size: 15 KB 网页链接
$Myomo(MYO)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0000950170-24-038054 Act: 34 Size: 205 KB 网页链接
$Myomo(MYO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-032523 Size: 4 KB 网页链接